These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8834621)

  • 1. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W; Chyrek-Borowska S
    Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A; Loustanau O; Tahar HA; Menelet I
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
    Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
    Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequential analysis of specific IgE and IgG titres as a function of the cumulated doses of venoms injected in allergies to Hymenoptera and correlation with specific IgE, clinical manifestations and skin tests].
    Hutt N; Hutt-Kempf E; Thierry R; Pauli G; Guilloux L
    Allerg Immunol (Paris); 1988 Jan; 20(1):18-9, 22. PubMed ID: 3390295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
    Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
    Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
    Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
    Gentlesk MJ; Halpern GM; Mansmann HC
    Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.